Reata Pharmaceuticals, Inc. (Nasdaq: RETA) to Ring The Nasdaq Stock Market Closing Bell
May 26 2016 - 6:00AM
What:Reata Pharmaceuticals, Inc. (Nasdaq:RETA),
will visit the Nasdaq MarketSite in Times Square in celebration of
the company’s initial public offering (IPO) on May 26, 2016.
In honor of the occasion, Warren Huff, President and
Chief Executive Officer, will ring the Closing
Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Thursday, May 26, 2016 – 3:45 p.m. to 4:00
p.m. ET
Reata Media Contact:Lee Stern(646)
378-2922media@reatapharma.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Reata Pharmaceuticals, Inc.Reata
Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company
focused on identifying, developing, and commercializing product
candidates that modulate the activity of key regulatory proteins
involved in the biology of mitochondrial function, oxidative
stress, and inflammation to address the unmet medical needs of
patients with a variety of serious or life-threatening diseases. We
focus on drugs with novel mechanisms of action that modulate
important regulatory proteins, called transcription factors, that
coordinate the cellular response to stressors by activating or
suppressing the activity of many target proteins. The effects of
AIM pharmacology have been documented in more than 200 scientific
papers and are potentially relevant to a wide range of
diseases.
To learn more about Reata Pharmaceuticals visit
www.reatapharma.com or follow us on Twitter @ReataPharma and
LinkedIn -
https://www.linkedin.com/company/reata-pharmaceuticals.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables
customers to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 70 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
more than 3,700 listed companies with a market value of
approximately $9.3 trillion and nearly 17,000 corporate clients. To
learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2024 to May 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2023 to May 2024